Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia.

Saved in:
Bibliographic Details
Title: Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia.
Authors: Heerspink, Hiddo J L1,2 (AUTHOR) h.j.lambers.heerspink@umcg.nl, Stack, Austin G3 (AUTHOR), Terkeltaub, Robert4 (AUTHOR), Greene, Tom A5 (AUTHOR), Inker, Lesley A6 (AUTHOR), Bjursell, Magnus7 (AUTHOR), Perl, Shira8 (AUTHOR), Rikte, Tord7 (AUTHOR), Erlandsson, Fredrik7 (AUTHOR), Perkovic, Vlado2 (AUTHOR)
Source: Nephrology Dialysis Transplantation. Aug2022, Vol. 37 Issue 8, p1461-1471. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09310509
DOI:10.1093/ndt/gfab237